A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis

NCT07102888 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis in Children
Plaque Psoriasis in Adolescents

Interventions

DRUG: RSS0393 Ointment

Sponsor

Jiangsu HengRui Medicine Co., Ltd.